(Press-News.org) PULLMAN, Wash. -- It isn’t just people – when given the chance rats may also use cannabis to cope with stress, according to a study by researchers at Washington State University.
Published in the journal Neuropsychopharmacology, the study was designed to examine cannabis-seeking behavior and found that rats with higher natural stress levels are far more likely to self-administer the popular recreational drug.
"We ran rats through this extensive battery of behavioral and biological tests, and what we found was that when we look at all of these different factors and all the variables that we measured, stress levels seem to matter the most when it comes to cannabis use,” said Ryan McLaughlin, associate professor in WSU’s College of Veterinary Medicine.
Looking at traits ranging from social behaviors to sex, cognition, reward, and arousal, McLaughlin and his team of undergraduate and graduate student researchers created a behavioral profile for each rat. Then, over the course of three weeks, rats were observed for one hour daily as they were given the option to self-administer cannabis by poking their nose in a vapor port to release a three-second dispersal of cannabis vapor in an air-tight chamber.
During that one-hour period, student researchers tracked the number of “nose-pokes” by each rat and found a direct correlation to the number of nose-pokes and baseline stress hormone levels.
By measuring the stress hormone corticosterone in the rodents, the equivalent to the stress hormone cortisol in humans, the team found rats with higher natural stress hormone levels were far more likely to self-administer cannabis.
“If you want to really boil it down, there are baseline levels of stress hormones that can predict rates of cannabis self-administration, and I think that only makes sense given that the most common reason that people habitually use cannabis is to cope with stress,” McLaughlin said.
He said it’s important to note that it was a rat’s resting baseline stress levels that were associated with cannabis self-administration, not stress that fluctuates in real time with exercise or mentally challenging tasks. Stress hormone levels were also calculated after exposure to a stressor and showed no significant link to cannabis-seeking behavior.
There were also significant relationships between rates of cannabis self-administration and measures of “cognitive flexibility”, which is our ability to adapt to changing rules.
“Animals that were less flexible in shifting between rules, when we tested them in a cognitive task, tended to show stronger rates of cannabis-seeking behavior,” he said. “So, animals that rely more heavily on visual cues to guide their decision making, those rats, when we tested their motivation to self-administer cannabis vapor, were also very highly motivated rats.”
The study also identified a link between high morning corticosterone and low endocannabinoid levels to cannabis self-administration, although not as strongly as baseline stress.
Endocannabinoids are compounds produced on demand to help the body maintain a state of physiological balance, or homeostasis.
“There's some thought behind why people might be more prone to use cannabis, and that maybe THC serves as a reasonable substitute for endocannabinoids in individuals that have lower endocannabinoid levels,” McLaughlin said. “So, perhaps there's more of a drive to supplement that with cannabis.”
With more and more states decriminalizing cannabis and legalizing recreational cannabis, McLaughlin said it’s critical to understand the effects of the drug and the grips of drug abuse.
“Our findings highlight potential early or pre-use markers that could one day support screening and prevention strategies,” McLaughlin said. “I could certainly envision a scenario where having an assessment of baseline cortisol might provide some level of insight into whether there's an increased propensity for you to develop problematic drug use patterns later in life.”
END
Rats may seek cannabis to cope with stress
2025-12-11
ELSE PRESS RELEASES FROM THIS DATE:
New FAU research strengthens evidence linking alcohol use to cancer
2025-12-11
As Americans gear up for the holiday season, new research offers a timely reminder to reflect on the long-term health effects of raising a celebratory glass – or two. Alcohol is known to increase the risk of several cancers even at moderate levels. Yet drinking remains widespread, and important questions persist about how both the frequency and amount of alcohol people consume shape their cancer risk.
Moreover, risks differ across groups, and existing alcohol policies rarely emphasize their link to cancer.
To help close these critical gaps, researchers from Florida Atlantic University’s Charles E. Schmidt College of Medicine, conducted a comprehensive systematic ...
Gut health à la CAR T
2025-12-11
Ever notice that as you get older, some foods no longer sit with you the same? This could be due to a breakdown of the intestinal epithelium, a single layer of cells that forms the organ’s lining. The intestine plays a crucial role in many health functions, including digestion. Under normal conditions, the entire intestinal epithelium typically regenerates every three to five days. However, with damage from old age or cancer radiation, regeneration can stop or slow. That can lead to inflammation and diseases like leaky gut syndrome.
Now, Cold Spring ...
Dr. Pengfei Liu receives 2026 O'Donnell Award in Medicine for pioneering advances in genetic diagnostics and rare disease treatment
2025-12-11
Trailblazing geneticist Pengfei Liu, Ph.D., Associate Professor in the Department of Molecular and Human Genetics at Baylor College of Medicine, is the recipient of the 2026 Edith and Peter O’Donnell Award in Medicine from TAMEST. He was chosen for his transformative use of genome and RNA sequencing to improve the diagnosis and treatment of rare genetic diseases.
A global leader in his field, Dr. Liu has consistently expanded the boundaries in the diagnosis and treatment of rare genetic disorders. His contributions span nearly every major advancement in modern clinical genetics – from early discoveries of genome rearrangement mechanisms ...
Dr. Yunsun Nam receives 2026 O'Donnell Award in Biological Sciences for pioneering RNA research transforming gene regulation and cancer therapy
2025-12-11
Renowned molecular biologist Yunsun Nam, Ph.D., Professor in the Departments of Biochemistry and Biophysics and the Doris and Bryan Wildenthal Distinguished Chair in Medical Science at UT Southwestern Medical Center, is the recipient of the 2026 Edith and Peter O’Donnell Award in Biological Sciences from TAMEST. She was chosen for her groundbreaking research into how RNAs and proteins interact at the molecular level – providing key insights for gene regulation, cancer biology and RNA-based therapeutics.
Crucial ...
Dr. Bilal Akin wins 2026 O'Donnell Award in Engineering for transformative work in EV energy systems and industrial automation
2025-12-11
Groundbreaking electrical engineer Bilal Akin, Ph.D., Professor in the Department of Electrical and Computer Engineering at The University of Texas at Dallas, is the recipient of the 2026 Edith and Peter O’Donnell Award in Engineering from TAMEST. He was chosen for his cutting-edge advancement of sustainable and high-efficiency energy conversion systems for electric vehicles (EVs) and industrial automation.
Dr. Akin’s research focuses on making power electronics systems more efficient, reliable and sustainable, with major ...
Dr. Fan Zhang receives 2026 O'Donnell Award in Physical Sciences for groundbreaking discoveries in quantum matter and topological physics
2025-12-11
Pioneering theoretical physicist Fan Zhang, Ph.D., Professor in the Department of Physics at The University of Texas at Dallas, is the recipient of the 2026 Edith and Peter O’Donnell Award in Physical Sciences from TAMEST. He was chosen for his transformational research exploring new topological quantum matter, which has changed how we think about physics.
Dr. Zhang studies how millions of electrons in atomically thin materials interact to produce collective quantum effects such as magnetic, superconducting and topological phases. His ...
Dr. Yue Hu receives 2026 O'Donnell Award for revolutionizing energy operations with real-time AI and reinforcement learning
2025-12-11
Artificial Intelligence (AI) innovator Yue Hu, Ph.D., AI Specialist – Production Technology at bp, is the recipient of the 2026 Edith and Peter O’Donnell Award in Technology Innovation from TAMEST. She was chosen for her cutting-edge work applying AI to optimize real-time industrial processes in the energy sector.
Dr. Hu specializes in reinforcement learning (RL), an AI approach that learns by trial and error. While RL has proven powerful in fields like robotics and gaming, it had rarely been applied successfully to high-stakes oilfield operations. By combining AI with bp’s powerful computing systems, Dr. Hu has successfully applied RL ...
Greater risk that the political right falls for conspiracy theories
2025-12-11
People who lean politically to the right are more likely to fall for conspiracy theories than those on the left – but not for other types of false or misleading information. And regardless of ideology, we tend to accept political claims that align with our own beliefs. This is shown in a doctoral thesis from Linköping University, Sweden.
“Conspiracy theories can have a very strong mobilising force, as seen during the storming of the Capitol. Several of those who took part believe in conspiracy ...
JMC Publication: Insilico’s AI platforms enable discovery of potent, selective, oral DGKα inhibitor to overcome checkpoint resistance
2025-12-11
Insilico Medicine has developed a new class of small molecule inhibitors targeting diacylglycerol kinase alpha (DGKα) designed to restore T cell function and overcome resistance to immune checkpoint blockades in solid cancers. The latest results from this program have just been published in the Journal of Medicinal Chemistry, describing the discovery and comprehensive preclinical evaluation of Compound 10, a novel, potent, selective and orally administered DGKα inhibitor. The compound exhibits a differentiated pharmacokinetic and safety profile and ...
Targeting collagen signaling boosts drug delivery in pancreatic cancer
2025-12-11
Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in oncology. One of the key reasons lies in the disease’s unique fibrotic microenvironment—a dense, collagen-rich tissue that acts as a physical and biochemical barrier, preventing drugs from reaching tumor cells effectively.
Now, a research team from Okayama University and Tohoku University has uncovered a promising new way to breach this barrier. Led by Assistant Professor Hiroyoshi Y. Tanaka from the Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, the group demonstrated that blocking ...